JP Morgan Chase’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,135
Closed -$178 7997
2023
Q3
$178 Hold
1,135
﹤0.01% 6853
2023
Q2
$293 Hold
1,135
﹤0.01% 6595
2023
Q1
$0 Hold
1,135
﹤0.01% 7386
2022
Q4
$0 Sell
1,135
-1,476
-57% -$1.49K ﹤0.01% 7168
2022
Q3
$3K Buy
2,611
+915
+54% +$1.62K ﹤0.01% 6213
2022
Q2
$5K Sell
1,696
-19,257
-92% -$80.9K ﹤0.01% 6181
2022
Q1
$158K Buy
20,953
+3,672
+21% +$30.4K ﹤0.01% 5303
2021
Q4
$242K Buy
17,281
+1,515
+10% +$29.9K ﹤0.01% 5242
2021
Q3
$408K Buy
15,766
+478
+3% +$15.2K ﹤0.01% 4844
2021
Q2
$699K Buy
15,288
+3,761
+33% +$178K ﹤0.01% 4506
2021
Q1
$507K Buy
11,527
+5,350
+87% +$260K ﹤0.01% 4666
2020
Q4
$190K Buy
6,177
+1,548
+33% +$49.1K ﹤0.01% 4826
2020
Q3
$143K Buy
+4,629
New +$114K ﹤0.01% 4537

Other funds holding AMTI

JP Morgan Chase's AMTI Position: Q4 2023 in Review

JP Morgan Chase sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q4 2023, closing a stake of 1,135 shares — an estimated $178 sold.

JP Morgan Chase first reported a position in AMTI in Q3 2020 and held it in 13 quarters. The position peaked at $699K in Q2 2021. 2 funds tracked by Wall St. Rank hold AMTI as of Q4 2023.

  • JP Morgan Chase reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • JP Morgan Chase sold 1,135 Applied Molecular Transport Inc. Common Stock shares in Q4 2023, an estimated $178.
  • JP Morgan Chase first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • JP Morgan Chase's Applied Molecular Transport Inc. Common Stock position peaked at $699K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.